These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 6380230

  • 1. Adverse effects of tricyclic antidepressants: focus on the elderly.
    Glassman AH, Carino JS, Roose SP.
    Adv Biochem Psychopharmacol; 1984; 39():391-8. PubMed ID: 6380230
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular effects of the antidepressants: recognition and control.
    Chutka DS.
    Geriatrics; 1990 Jan; 45(1):55-9, 62, 67. PubMed ID: 1688541
    [Abstract] [Full Text] [Related]

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.
    J Clin Psychiatry; 2004 Jan; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [Abstract] [Full Text] [Related]

  • 4. Antidepressant drugs: disturbing and potentially dangerous adverse effects.
    Settle EC.
    J Clin Psychiatry; 1998 Jan; 59 Suppl 16():25-30; discussion 40-2. PubMed ID: 9796863
    [Abstract] [Full Text] [Related]

  • 5. Using tricyclic antidepressants in the elderly.
    McCue RE.
    Clin Geriatr Med; 1992 May; 8(2):323-34. PubMed ID: 1600482
    [Abstract] [Full Text] [Related]

  • 6. Management of antidepressant-induced side effects: a practical guide for the clinician.
    Pollack MH, Rosenbaum JF.
    J Clin Psychiatry; 1987 Jan; 48(1):3-8. PubMed ID: 3804983
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: importance of blood level monitoring.
    Smith RC, Chojnacki M, Hu R, Mann E.
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):57-63. PubMed ID: 7440526
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular toxicity and tricyclic antidepressants.
    Jackson WK, Roose SP, Glassman AH.
    Biomed Pharmacother; 1987 Dec; 41(7):377-82. PubMed ID: 3328632
    [Abstract] [Full Text] [Related]

  • 9. Recent pharmacologic advances in antidepressant therapy for the elderly.
    Preskorn SH.
    Am J Med; 1993 May 24; 94(5A):2S-12S. PubMed ID: 8503477
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of tricyclic antidepressants.
    Glassman AH.
    Annu Rev Med; 1984 May 24; 35():503-11. PubMed ID: 6372670
    [Abstract] [Full Text] [Related]

  • 11. The safety profile of nefazodone.
    Robinson DS, Roberts DL, Smith JM, Stringfellow JC, Kaplita SB, Seminara JA, Marcus RN.
    J Clin Psychiatry; 1996 May 24; 57 Suppl 2():31-8. PubMed ID: 8626361
    [Abstract] [Full Text] [Related]

  • 12. Incidence of orthostatic hypotension in patients with primary affective disorders treated with tricyclic antidepressants.
    Hayes JR, Born GF, Rosenbaum AH.
    Mayo Clin Proc; 1977 Aug 24; 52(8):509-12. PubMed ID: 881903
    [Abstract] [Full Text] [Related]

  • 13. [Antidepressants consumption in the global population in France].
    Olié JP, Elomari F, Spadone C, Lépine JP.
    Encephale; 2002 Aug 24; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K, Tybring G, Härtter S, Andersson K, Svensson JO, Widén J, Bertilsson L.
    Clin Pharmacol Ther; 2001 Oct 24; 70(4):327-35. PubMed ID: 11673748
    [Abstract] [Full Text] [Related]

  • 15. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N, Siobud-Dorocant E, Even C, Slama F, Dardennes R.
    Encephale; 2001 Oct 24; 27(4):373-6. PubMed ID: 11686060
    [Abstract] [Full Text] [Related]

  • 16. The problems of safety and compliance with conventional antidepressant drugs.
    Lader M.
    Acta Psychiatr Scand Suppl; 1983 Oct 24; 308():91-5. PubMed ID: 6583984
    [Abstract] [Full Text] [Related]

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Oct 24; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 18. Unwanted effects of psychotropic drugs. III. Drugs for depression.
    Edwards JG.
    Practitioner; 1977 Jun 24; 218(1308):862-6. PubMed ID: 882500
    [No Abstract] [Full Text] [Related]

  • 19. Tricyclic antidepressant overdose.
    Smith RK, O'Mara K.
    J Fam Pract; 1982 Aug 24; 15(2):247-53. PubMed ID: 7097164
    [Abstract] [Full Text] [Related]

  • 20. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr 24; 18(100):75-9. PubMed ID: 19585728
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.